VIDA DIAGNOSTICS, INC.
AI-powered imaging analysis software that extracts digital biomarkers from clinical trial imaging data
- Sector
- Medtech
- Headquarters
- Coralville, IA
- Founded
- 2005
- Latest Form D
- $10.8M, Sep 2023
- Total capital
- $27.7M
- Federal grants
- $300K
- 1 award · 2016
- Rank in peer group#4 of 50
- Private capital raised
- $27.4M
- 4 Form D · last Sep 2023
- 37 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 12
- 24 pending · first 2015
- Rank in peer group#2 of 50
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$10.8M
- Private capital raisedForm D · SEC · 3rd filing$11.1M
- Private capital raisedForm D · SEC · 2nd filing$5.1M
- Federal grantHealth and Human S · Phase I · Precision, pulmonary disease evaluation and lung cancer detection using quantitative low-dose CT$300K
- Private capital raisedForm D · SEC · 1st filing$300K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 50 peers
Line = medianMedtech · Software
- Federal grants#4 · top 8%
- Granted patents#2 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Craig A. IbsenDirectorNamed in SEC Form D filings
- David A. HuntDirectorNamed in SEC Form D filings
- Dennis WangemanDirectorNamed in SEC Form D filings
- Eric HoffmanDirectorNamed in SEC Form D filings
- Erkan A. AkyuzDirectorNamed in SEC Form D filings
- John GarberExecutive Officer, Director, PromoterNamed in SEC Form D filings
Show all 16 people
- Karen A. DrexlerDirectorNamed in SEC Form D filings
- Matthew B. WarrensDirectorNamed in SEC Form D filings
- Michael SimsDirectorNamed in SEC Form D filings
- Phillip B. SternDirectorNamed in SEC Form D filings
- Phil A. SternDirectorNamed in SEC Form D filings
- Robert B. BozemanDirectorNamed in SEC Form D filings
- Scott A. HoekmanDirectorNamed in SEC Form D filings
- Susan WoodDirectorNamed in SEC Form D filings
- Susan A. Wood, PhDExecutive Officer, DirectorNamed in SEC Form D filings
- Tracy A. MarshbanksDirectorNamed in SEC Form D filings
What it has protected
USPTO · 12 granted of 36- PendingMethod Of Quantifying And Scoring Lung Mucus PlugsUSPTOApplication 19210304
- GrantedVisualization Of Sub-pleural RegionsUSPTOUS 12,266,111
- PendingMethod Of Quantifying Lung DiseaseUSPTOApplication 18666070
Show all 36 patent records
- Method Of Quantifying And Scoring Lung Mucus PlugsNov 20, 2025 · Application 19210304Pending
- Visualization Of Sub-pleural RegionsApr 1, 2025 · US 12,266,111Granted
- Method Of Quantifying Lung DiseaseNov 21, 2024 · Application 18666070Pending
- Pulmonary Analysis Using Transpulmonary PressureSep 10, 2024 · US 12,086,980Granted
- Subject Specific Coordinatization And Virtual Navigation Systems And MethodsJan 16, 2024 · US 11,875,459Granted
- Airway Mucus VisualizationNov 16, 2023 · Application 18316840Pending
- Treatment Outcome Prediction For Lung Volume Reduction ProceduresApr 19, 2022 · US 11,304,756Granted
- Cut-surface Display Of Tubular StructuresNov 16, 2021 · US 11,176,666Granted
- Visualization And Quantification Of Lung Disease Utilizing Image RegistrationApr 9, 2019 · US 10,255,679Granted
- Systems And Methods For Quantifying Regional Fissure FeaturesMar 14, 2019 · Application 16183772Pending
- Treatment Outcome Prediction For Lung Volume Reduction ProceduresMar 12, 2019 · US 10,226,299Granted
- Systems And Methods For Quantifying Regional Fissure FeaturesJan 1, 2019 · US 10,165,964Granted
- Visualization And Quantification Of Lung Disease Utilizing Image RegistrationSep 12, 2017 · US 9,760,989Granted
- Treatment Outcome Prediction For Lung Volume Reduction ProceduresNov 29, 2016 · US 9,504,529Granted
- Visualization And Characterization Of Pulmonary Lobar FissuresJul 12, 2016 · US 9,390,498Granted
- Visualization And Characterization Of Pulmonary Lobar FissuresApr 21, 2015 · US 9,014,445Granted
- Treatment Planning For Lung Volume Reduction ProceduresSep 18, 2014 · Application 14209451Pending
- Treatment Planning For Lung Volume Reduction ProceduresApplication 61782308Pending
- Visualization and Characterization of Pulmonary Lobar FissuresApplication 61712700Pending
- Systems And Methods For Navigation Within A Branched Structure Of A BodyApplication PCTUS2009036281Pending
- Method Of Quantifying And Scoring Lung Mucus PlugsApplication 63648953Pending
- Method Of Quantifying Lung DiseaseApplication PCTUS2024029635Pending
- Method Of Quantifying Lung DiseaseApplication 63595138Pending
- Method of Quantifying Lung DiseaseApplication 63503118Pending
- Airway Mucus VisualizationApplication 63433011Pending
- Airway Mucus VisualizationApplication 63341940Pending
- Visualization Of Sub-pleural RegionsApplication 63118808Pending
- Correction of Lung Tissue Measurements Based on Transpulmonary Pressure Gradient EstimationApplication 63106345Pending
- Subject Specific Coordinatization And Virtual Navigation SystemApplication 63006691Pending
- Cut-surface Display Of Tubular StructuresApplication PCTUS2019060407Pending
- Cut-surface Display Of Tubular StructuresApplication 62758309Pending
- Systems And Methods For Quantifying Regional Fissure FeaturesApplication PCTUS2016031306Pending
- Visualization And Quantification Of Lung Disease Utilizing Image RegistrationApplication PCTUS2015030704Pending
- Lung Imaging Surrogates Of Collateral VentilationApplication 62159098Pending
- Treatment Outcome Prediction For Lung Volume Reduction ProceduresApplication PCTUS2015017077Pending
- Treatment Planning For Lung Volume Reduction ProceduresApplication PCTUS2014026348Pending
Related companies, and why
- Leith Medical, Inc.Similar federal contract value in Medtech · null in contracts
- ADAPTILENS, INC.Similar federal contract value in Medtech · null in contracts
- EXCELSIOR BIOFILMS, LLCSimilar federal contract value in Medtech · null in contracts
- Yesse Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- Pace Surgical, Inc.Similar federal contract value in Medtech · null in contracts
- ERISYON INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .